At a glance
- Originator Nonindustrial source
- Class Benzoic acids
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections; Immunodeficiency disorders
Most Recent Events
- 02 Dec 2003 Discontinued - Preclinical for HIV infections treatment in United Kingdom (unspecified route)
- 02 Dec 2003 Discontinued - Preclinical for Immunodeficiency disorders in United Kingdom (unspecified route)
- 18 May 2001 No-Development-Reported for HIV infections treatment in United Kingdom (Unknown route)